Want to see AONC full AI Analyst Report?
AONC Stock Chart & Stats
$13.00
$0.00(0.00%)
At close: 4:00 PM EST
$13.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.05 - $13.95
Previous CloseN/A
Volume3.00
Average Volume (3M)90.00
Market Cap
$503.37M
Enterprise Value$10.00T>
Total Cash (Recent Filing)$72.64M
Total Debt (Recent Filing)$147.37M
Price to Earnings (P/E)―
Beta0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding33,732,370
10 Day Avg. Volume78
30 Day Avg. Volume90
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)3.70
Price to Sales (P/S)0.04
P/FCF Ratio-2.68
Enterprise Value/Market Cap748.96K
Enterprise Value/Revenue214.27K
Enterprise Value/Gross Profit3.20M
Enterprise Value/Ebitda207.71M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Top-line GrowthSustained multi-year revenue expansion indicates the platform is successfully scaling affiliated practices and ancillary services. Durable top-line growth supports network effects, bargaining power with payers and vendors, and provides a larger base to invest in operations and clinical programs over the medium term.
Physician-led Community PlatformA physician-led, management-services model aligns incentives with independent practices and anchors long-term contractual relationships. This structure supports recurring management fees, local clinical trust, and deeper integration of ancillary services—advantages that sustain penetration of outpatient oncology care.
Data Intelligence PartnershipEmbedding intelligent data workflows is a structural change that can improve trial enrollment, operational efficiency, and clinical decision support. Over months, this can differentiate the network, unlock research revenue streams, and reduce administrative friction across affiliated practices.
Bears Say
Persistent LossesOngoing unprofitability undermines internal funding for growth and clinical investments, forcing reliance on external financing. Over a multi-month horizon, persistent losses increase refinancing risk, constrain strategic flexibility, and can impede execution of expansion or integration initiatives.
Weak Balance SheetNegative equity signals structural capital weakness that limits borrowing capacity and increases vulnerability to adverse shocks. This weak balance sheet can raise lender covenants, hinder acquisitions or capital projects, and constrain the company's ability to sustain operations during cyclical stress.
Negative Operating And Free Cash FlowContinued negative operating and free cash flow indicates the core business is not self-funding. Reliance on financing to cover operations reduces runway for strategic investments, increases interest and dilution risks, and limits the company's ability to scale infrastructure or absorb integration costs.
American Oncology Network News
AONC FAQ
What was American Oncology Network’s price range in the past 12 months?
American Oncology Network lowest stock price was $0.05 and its highest was $13.95 in the past 12 months.
What is American Oncology Network’s market cap?
American Oncology Network’s market cap is $503.37M.
When is American Oncology Network’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were American Oncology Network’s earnings last quarter?
Currently, no data Available
Is American Oncology Network overvalued?
According to Wall Street analysts American Oncology Network’s price is currently Overvalued.
Does American Oncology Network pay dividends?
American Oncology Network does not currently pay dividends.
What is American Oncology Network’s EPS estimate?
American Oncology Network’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does American Oncology Network have?
American Oncology Network has 33,732,370 shares outstanding.
What happened to American Oncology Network’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of American Oncology Network?
Currently, no hedge funds are holding shares in AONC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
American Oncology Network
American Oncology Network, Inc. engages in the provision of community-based oncology management. The firm provides various services to patients, including laboratory services for routine and specialized testing, in-house professional and technical pathology services with pathology reports, in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance, and care management support services, including nutrition guidance. The company was founded in 2018 and is headquartered in Fort Myers, FL.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.08% Other Institutional Investors
99.92% Public Companies and
Individual Investors